Solid Tumor Profiling
Molecular Profiling of Solid Tumor Samples
One of the major challenges in clinical oncology research is the high degree of tumor heterogeneity. Understanding the genetic makeup of tumor specimens is critical for elucidating the underlying biology. Detection of mutations with critical clinical implications but present in low frequencies is especially important in solid tumor malignancies as the information can help to identify patients in more aggressive states of the disease.
Next-generation sequencing (NGS) using amplicon-based panels is an ideal method to obtain a comprehensive view of the tumor’s genomic profile. Amplicon-based NGS panels can accurately, quickly, and economically detect clinically meaningful mutations present at low levels within the tumor.
CleanPlex® NGS Panels – the Best-in-Class Tumor Profiling Solution for Every NGS Lab
Most Accurate, Reproducible, and Highest-Quality Results from FFPE Samples
The CleanPlex® OncoZoom® Cancer Hotspot Panel is a multiplex PCR-based targeted sequencing assay designed for rapid detection of somatic mutations across 2,900+ hotspot regions of 65 oncogenes and tumor suppressor genes. Sequencing-ready libraries can be prepared using a single-tube workflow in just 3 hours. The panel is optimized to deliver data with high on-target performance and high coverage uniformity to ensure efficient use of sequencing reads.
The expert team at SOPHiA GENETICS compared the performance of CleanPlex OncoZoom Cancer Hotspot Panel to three other commercially-available amplicon-based cancer hotspot panels using DNA samples of varying quality and quantity extracted from FFPE tissues. They found that Paragon Genomics’ CleanPlex OncoZoom Cancer Hotspot Panel provided the highest coverage uniformity and produced a high library conversion rate. When combined with SOPHiA for genomic analysis, the panel’s high-quality data enabled accurate and reproducible variant detection.
Highest Coverage Uniformity
Sophia Genetics has compared CleanPlex OncoZoom Panel with three other similar-sized cancer panels based on three other major amplicon-based technologies. The following amplification plots show that CleanPlex has the best amplification uniformity (all amplicons’ read depths fall within 20% an 500% of mean depth while other technologies cannot achieve this). The study was published by Sophia Genetics at AMP 2018 Conference. Besides amplification uniformity, Sophia Genetics also concluded that CleanPlex has high library conversion rate and reproducibility even on bad quality FFPE samples.
A High-Performance Solution Combining CleanPlex® OncoZoom® Cancer Hotspot Panel and SOPHiA AI for Rapid Characterization of Somatic Mutations
Download our joint technical note with SOPHiA GENETICS to see the full dataset demonstrating CleanPlex’s superior performance.